期刊
SCANDINAVIAN JOURNAL OF IMMUNOLOGY
卷 69, 期 1, 页码 11-19出版社
WILEY
DOI: 10.1111/j.1365-3083.2008.02190.x
关键词
-
类别
资金
- Department of Biotechnology
- Department of Science and Technology (DST)
- Council for Scientific and Industrial Research (CSIR), Government of India
- ICMR (Center for Advanced Study in Molecular Medicine)
- University Grants Commission
Cyclooxygenase-2 (COX-2) is implicated in pathophysiological processes associated with the initiation or maintenance of host inflammatory responses to infection. Our results demonstrates that Mycobacterium bovis BCG (M. bovis BCG) downregulates tumour necrosis factor-alpha (TNF-alpha)-induced COX-2 gene expression in alveolar epithelial cells by inhibiting the phosphorylations of Raf-1 and p38 kinases. Further, M. bovis BCG-mediated inhibition of COX-2 or p38 mitogen-activated protein kinase could be reversed by Calyculin A, a selective inhibitor of Ser/Thr phosphatases. Moreover, M. bovis BCG inhibited the TNF-alpha-triggered NF-kappa B activation following I kappa B degradation. Taken together, these results suggest that the attenuation of COX-2 expression by vaccine strain, M. bovis BCG, represents a novel strategy to maintain robust host proinflammatory responses to subsequent challenges with virulent tuberculosis bacilli.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据